Navigation Links
IBM and Imago find a crucial difficulty in semiconductor device scaling
Date:9/6/2007

In 1959, Nobel Prize winner Richard Feynman presented a talk entitled There's Plenty of Room at the Bottom. Feynman concluded that there was no physical reason why humans couldn't manipulate atoms. However, if atomic manipulation is achieved the question of observing the new atom positions remains. How do you know what you have done"

As reported in the Sept. 7, 2007 issue of Science, IBM and Imago have taken a seminal step along the path to achieving Dr. Feynmans vision by observing, for the first time, distributions of individual dopant atoms in semiconductor devices. Atom probe tomography was used to quantify the location and elemental identity of the atoms proximate to defects in silicon. The dopants were implanted into the silicon uniformly and it was always hoped that the distribution of dopant atoms would be uniform. However, the IBM and Imago researchers found that clusters (more properly Cottrell atmospheres) of dopant atoms form around defects after ion implantation and annealing. Furthermore, these atmospheres persist in surrounding dislocation loops even after considerable thermal treatment creating dopant fluctuations that may ultimately limit the scalability of semiconductor devices.

This is the first time that unambiguous quantitative 3D information regarding the precise location of individual dopant atoms relative to defects has been available said study co-author and Imago CEO Tom Kelly. The ability of the Imago LEAP 3000X Si laser assisted atom probe to make this measurement is the fruition of many years of instrumentation and applications development. We now have a powerful new way to probe the atomic positions of dopants in a semiconductor device. This is a critical tool for scientists seeking to answer Professor Feynmans challenge to manipulate matter at the atomic level and hence enable nanotechnology.

Previously, researchers have used secondary ion mass spectrometry (SIMS) and transmission electron microscopy (TEM) to correlate indirectly the presence of dopant atoms with the evolution of defects, and detailed models have been proposed to account for these experimental correlations. However, the atom probe study published in Science reports, for the first time, the location of individual dopant atoms. Said Imago Senior Director of Applications and co-author David Larson, The Sept. 7 Science article is the most recent in a series of significant scientific advances reported by Imagos customers. Added Dr. Larson, In addition to producing breakthrough published scientific results, the Imago atom probe is also being applied to various industrial problems. These proprietary results are advancing scientific knowledge, enabling the development of new products, and improving time to market for our customers.


'/>"/>
Contact: Jason Schneir
jschneir@imago.com
608-274-6880 x239
Imago Scientific Instruments
Source:Eurekalert

Related biology technology :

1. Imago sells microscope to Iowa State
2. Imago upgrades atom-probe microscope
3. Imago earns more acclaim for microscope
4. Northwestern adds to its Imago microscope
5. Investors commit $3.4 million to Imago
6. Imago acquires synergistic British firm
7. Imago microscope leads to Northwestern research advance
8. Tech Digest: Imago; RedPrairie
9. UW-Madison helps Imago carry out its big vision for seeing small
10. Japanese institute installs Imago system
11. Imago provides atomic probe to Australian lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... G. Fujimoto, Ph.D ., the Elihu Thomson Professor of Electrical Engineering and Computer ... Research Award winner. Presented annually, the award recognizes an individual who has ...
(Date:7/20/2017)... ... , ... VIC Technology Venture Development™ (VIC™), is pleased to announce ... addition continues to strengthen and diversify VIC’s board. , "We are excited to have ... highly accomplished business executive with a broad range of experience directly relevant to VIC ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... the United States Patent and Trademark Office for its Patent Applications 14/858,857 and ... Office’s allowances of these patent applications further expand the protection of G-CON’s R&D ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):